Trials / Unknown
UnknownNCT02816047
Austrian Wearable Cardioverter Defibrillator Registry
Indications for and Experience With the Wearable Cardioverter Defibrillator (WCD) - Austrian WCD Registry
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 450 (estimated)
- Sponsor
- Medical University of Graz · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Background: The wearable cardioverter defibrillator (WCD) is an established treatment option for patients at high risk for ventricular tachycardia / ventricular fibrillation (VT/VF), either in whom this risk may only be temporarily present, or in patients at high risk for sudden cardiac death (SCD) or after VT/VF in whom an implantable cardioverter defibrillator (ICD is currently not possible for other reasons (infection, recent MI \<40days, recent PCI/CABG \< 3months etc.). Methods: Comprehensive registry including all patients in Austria who received a WCD in 2010-2016.
Detailed description
Observational study to describe WCD indications, event rates, inappropriate shock rates and follow up (including ICD rate, shock rate, morbidity and mortality) in all Austrian WCD patients
Conditions
- Heart Failure
- Ventricular Dysfunction
- Sudden Death
- Sudden Cardiac Arrest
- Ventricular Tachycardia
- Ventricular Fibrillation
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Registry | Observational study to describe WCD indications, event rates, inappropriate shock rates and follow up (including ICD rate, shock rate, morbidity and mortality) in all Austrian WCD patients |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2021-12-01
- Completion
- 2022-03-01
- First posted
- 2016-06-28
- Last updated
- 2021-09-14
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT02816047. Inclusion in this directory is not an endorsement.